483 Baxter Pharmaceutical Solutions Mar 2013

483 Baxter Pharmaceutical Solutions Mar 2013

Robert Barbosa FDA, Meisha Waters FDA, Meisha Sampson FDA$119.00 - Available Now

FDA investigators audited the Baxter Pharmaceutical Solutions - Bloomington, IN, United States facility and issued 2 inspectional observations (via FDA 483) on 12 Mar 2013.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 12 Mar 2013
  • Location: Bloomington, United States
  • FEI: 1000115571
Add To Cart